etherna
etherna develops mRNA-LNP delivery platforms and RNA design solutions for nucleic acid therapeutics.
etherna offers proprietary RNA and LNP platforms for nucleic acid medicine, including RNA design chemistry, LNP delivery technologies, and integrated RNA-LNP platforms. The company provides both research-grade and GMP-grade RNA solutions and offers technology partnering.
Key People
Bernard Sagaert - Chief Executive Officer